FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia

(MedPage Today) -- FDA staff appear to have serious doubts about the prospects of imetelstat as a treatment for transfusion-dependent anemia in adults with myelodysplastic syndromes (MDS), according to a briefing document released ahead of a meeting...
Source: MedPage Today Public Health - Category: American Health Source Type: news